We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transforming growth factor‐beta1 and myeloid‐derived suppressor cells: A cancerous partnership.
- Authors
Mojsilovic, Slavko; Mojsilovic, Sonja S.; Bjelica, Suncica; Santibanez, Juan F.
- Abstract
Transforming growth factor‐beta1 (TGF‐β1) plays a crucial role in tumor progression. It can inhibit early cancer stages but promotes tumor growth and development at the late stages of tumorigenesis. TGF‐β1 has a potent immunosuppressive function within the tumor microenvironment that largely contributes to tumor cells' immune escape and reduction in cancer immunotherapy responses. Likewise, myeloid‐derived suppressor cells (MDSCs) have been postulated as leading tumor promoters and a hallmark of cancer immune evasion mechanisms. This review attempts to analyze the prominent roles of both TGF‐β1 and MDSCs and their interplay in cancer immunity. Furthermore, therapies against either TGF‐β1 or MDSCs, and their potential synergistic combination with immunotherapies are discussed. Simultaneous TGF‐β1 and MDSCs inhibition suggest a potential improvement in immunotherapy or subverted tumor immune resistance. Key Findings: TGF‐β1; MDSCs; myeloid‐derived suppressor cells; T‐cell immunosuppression; tumor progression; cancer
- Subjects
MYELOID-derived suppressor cells; CARCINOGENS; CANCER invasiveness; TUMOR growth; TUMOR microenvironment
- Publication
Developmental Dynamics, 2022, Vol 251, Issue 1, p105
- ISSN
1058-8388
- Publication type
Article
- DOI
10.1002/dvdy.339